The leader of the Antiaging movement, Aubrey de Grey, has started a new antiaging foundation. The new foundation will be advancing combination antiaging damage repair therapies.
The new foundation will work with Ichor Life Sciences. Ichor spun out of Aubrey’s prior foundation. Ichor has macular regeneration work and has expanded to senenscent cells and acts as a CRO. A Contract Research Organization (CRO) is a company that provides clinical trial services for the pharmaceutical, biotechnology, and medical device industries.
Ichor (Stock symbol ICHR) has a market cap of about $800 million currently and has traded as high as $1.7 billion. Aubrey expects Ichor to get acquired.
Aubrey wants to press ahead to achieve his long standing goal of robust mouse rejuvenation.
Robust mouse rejuvenation as originally outlined means a full enough implementation of SENS (aging damage reversal) to be capable of doubling the remaining life expectancy of an elderly mouse, demonstrated and then replicated in rigorous laboratory studies.
I interviewed Aubrey de Grey recently where he discussed business and scientific highlights in the field of aging damage reversal.
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.
